Clearbridge Health Ltd. (SG:1H3)
SGX:1H3
Top Page
Clearbridge Health Ltd.
(SGX:1H3)
Select Model
Select Model
Rating:43Neutral
Price Target:
S$0.01
▲(0.00% Upside)
Action:UpgradedDate:03/19/26
The score is weighed down primarily by weak financial performance—widening losses and persistent cash burn—despite a notable 2025 revenue rebound. Valuation signals are also constrained by a negative P/E and no dividend data, while technical analysis is neutral due to missing indicators.
Positive Factors
Revenue rebound and stabilization
Stabilized revenue and a 33.9% rebound in 2025 indicate improving market traction and demand for core offerings. Over the next several quarters this foundation can enable scalable top-line growth, improve operating leverage potential, and reduce short-term revenue volatility if sustained.
Negative Factors
Persistent negative operating and free cash flow
Multi-year negative operating and free cash flow signal persistent cash burn that raises funding and dilution risk. Over a 2–6 month horizon this constrains investment in R&D, commercial expansion, or working capital, and makes the company reliant on external financing unless cash generation reverses.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue rebound and stabilization
Stabilized revenue and a 33.9% rebound in 2025 indicate improving market traction and demand for core offerings. Over the next several quarters this foundation can enable scalable top-line growth, improve operating leverage potential, and reduce short-term revenue volatility if sustained.
Read all positive factors
Clearbridge Health Ltd. (1H3) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$4.30M
Dividend YieldN/A
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)0.29
Revenue GrowthN/A
EPS GrowthN/A
CountrySG
Employees128
SectorHealthcare
Sector Strength45
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding4,295,821,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.91
Price to Sales (P/S)0.66
P/FCF Ratio-2.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Clearbridge Health Ltd. Business Overview & Revenue Model
Company Description
Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Ce...
How the Company Makes Money
null...
Clearbridge Health Ltd. Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
52
Neutral
Cash Flow
24
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 9.93M | 9.90M | 10.41M | 16.41M | 11.44M |
| Gross Profit | 5.06M | 4.78M | 5.13M | 9.58M | 6.36M |
| EBITDA | -11.61M | -2.06M | -32.17M | -7.63M | -7.65M |
| Net Income | -13.07M | -3.61M | -32.20M | -11.14M | -19.97M |
Balance Sheet | |||||
| Total Assets | 9.84M | 21.22M | 23.92M | 58.18M | 82.72M |
| Cash, Cash Equivalents and Short-Term Investments | 990.00K | 3.17M | 4.48M | 6.05M | 14.55M |
| Total Debt | 1.46M | 6.24M | 7.64M | 7.47M | 12.74M |
| Total Liabilities | 4.60M | 10.17M | 10.64M | 12.51M | 25.41M |
| Stockholders Equity | 3.45M | 9.21M | 10.19M | 42.32M | 52.21M |
Cash Flow | |||||
| Free Cash Flow | -2.71M | -2.10M | -4.12M | -2.67M | -3.83M |
| Operating Cash Flow | -2.66M | -1.93M | -3.57M | -1.98M | -2.99M |
| Investing Cash Flow | -57.00K | 1.18M | 3.07M | -1.08M | 1.18M |
| Financing Cash Flow | 541.00K | 266.00K | -1.88M | -2.56M | 2.46M |
Clearbridge Health Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
SG:1H3
Clearbridge Health Ltd.
―
―
―
SG:1B1
HC Surgical Specialists Ltd
0.37
0.11
40.68%
SG:1J5
Hyphens Pharma International Ltd.
0.32
0.04
16.67%
SG:MIJ
Alliance Healthcare Group Ltd.
0.16
0.05
53.47%
SG:OTX
Medinex Ltd.
0.23
0.05
25.00%
SG:PRH
Livingstone Health Holdings Limited
0.03
<0.01
13.04%
Clearbridge Health Ltd. Corporate Events
Clearbridge Health Reshuffles Remuneration Committee After Chairman’s Resignation
Feb 6, 2026
Clearbridge Health Limited has announced changes to its remuneration committee following the resignation of Non-Executive Non-Independent Chairman Mr. Chen Johnson, effective 27 February 2026, due to his taking up a new role at a professional serv...
Clearbridge Health’s Planned Elpis Biopharmaceuticals Acquisition Terminates as Term Sheet Lapses
Jan 23, 2026
Clearbridge Health Limited has announced that its binding term sheet for the proposed acquisition of Elpis Biopharmaceuticals Pte. Ltd. has lapsed as of 23 January 2026, after reaching the agreed long-stop date. The company stated that the lapse o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.